-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, September 1st.
The National Medical Insurance Administration today issued the "Notice on the List of Public Service Items for the Centralized Procurement of Medicines and Medical Consumables" (hereinafter referred to as the "Notice").
This notice is available to all pharmaceutical companies (especially those participating in national procurement) Directly or indirectly affects, the "Notice" mainly contains three items; Item 1: Centralized procurement of drugs and medical consumables information query (for the masses): You can query centralized procurement of drugs/medical consumables related information, such as drug medical insurance code, generic name, product name, dosage form, strength, packaging, quantity, manufacturer, approval number, hanging net price (excluding sign confidentiality agreements) and so on
.
Item 2: Consultation on centralized procurement of medicines and medical consumables (for enterprises, medical terminals, pharmacies, etc.
): If the period or policy of the procurement project is not yet clear, and the relevant departments need to verify, the specific response time shall prevail; log in to the system, It is handled online through the platform, no need to submit materials
.
The above two points are mainly based on: (Information source: the official website of the National Medical Insurance Administration) The third item: the price of medicines and the credit evaluation of recruitment and procurement (for enterprises ): I won’t say much about this (based on: "About the establishment of medical prices and recruitment and procurement Guiding Opinions on the Credit Evaluation System" (Medical Insurance Fa [2020] No.
34))
.
This piece of information has a relatively large amount of information, so I will briefly sort it out for everyone; 1.
Where to check: https://fuwu.
nhsa.
gov.
cn/nationalHallSt/#/home (picture source: National Medical Insurance Service Platform) Note: ① , Some information is not available yet, it is clearly written, and it will be perfected before the end of the year
.
②There is a difference between the content that can be queried by individual login and the content that can be queried by the unit.
③Important: After the information is perfected, the price of the selected national procurement can be checked (can the provincial belt volume mining/cross-regional alliance belt volume mining be searchable?)
.
Can the bidding price be checked for the regular provincial-level network? This point does not seem very clear
.
2.
Focus on the release of the guide: each province should have its own
.
(Information source: National Medical Insurance Bureau official website) I don’t know if it is about national procurement, provincial/inter-regional alliances, or all medicines/consumables related to the province? Now some provinces are struggling to go online after the evaluation, and there is no regular channel, and the time is not fixed.
If clear documents like Sichuan's are issued, it is obviously good for pharmaceutical companies
.
3.
"Untrustworthy" information is fully disclosed: At present, some provinces/national procurement agencies have released relevant "distrustworthy information".
However, this untrustworthy information requires companies to find their own companies or competing companies based on their ratings
.
Once the platform can be queried publicly, that is to say, as long as the information in it meets the relevant ratings, it can be "used" when recruiting.
This is a point that companies should focus on
.
This information access personnel and sales personnel need to pay attention to it, and the price is very important for a product
.
The National Medical Insurance Administration today issued the "Notice on the List of Public Service Items for the Centralized Procurement of Medicines and Medical Consumables" (hereinafter referred to as the "Notice").
This notice is available to all pharmaceutical companies (especially those participating in national procurement) Directly or indirectly affects, the "Notice" mainly contains three items; Item 1: Centralized procurement of drugs and medical consumables information query (for the masses): You can query centralized procurement of drugs/medical consumables related information, such as drug medical insurance code, generic name, product name, dosage form, strength, packaging, quantity, manufacturer, approval number, hanging net price (excluding sign confidentiality agreements) and so on
.
Item 2: Consultation on centralized procurement of medicines and medical consumables (for enterprises, medical terminals, pharmacies, etc.
): If the period or policy of the procurement project is not yet clear, and the relevant departments need to verify, the specific response time shall prevail; log in to the system, It is handled online through the platform, no need to submit materials
.
The above two points are mainly based on: (Information source: the official website of the National Medical Insurance Administration) The third item: the price of medicines and the credit evaluation of recruitment and procurement (for enterprises ): I won’t say much about this (based on: "About the establishment of medical prices and recruitment and procurement Guiding Opinions on the Credit Evaluation System" (Medical Insurance Fa [2020] No.
34))
.
This piece of information has a relatively large amount of information, so I will briefly sort it out for everyone; 1.
Where to check: https://fuwu.
nhsa.
gov.
cn/nationalHallSt/#/home (picture source: National Medical Insurance Service Platform) Note: ① , Some information is not available yet, it is clearly written, and it will be perfected before the end of the year
.
②There is a difference between the content that can be queried by individual login and the content that can be queried by the unit.
③Important: After the information is perfected, the price of the selected national procurement can be checked (can the provincial belt volume mining/cross-regional alliance belt volume mining be searchable?)
.
Can the bidding price be checked for the regular provincial-level network? This point does not seem very clear
.
2.
Focus on the release of the guide: each province should have its own
.
(Information source: National Medical Insurance Bureau official website) I don’t know if it is about national procurement, provincial/inter-regional alliances, or all medicines/consumables related to the province? Now some provinces are struggling to go online after the evaluation, and there is no regular channel, and the time is not fixed.
If clear documents like Sichuan's are issued, it is obviously good for pharmaceutical companies
.
3.
"Untrustworthy" information is fully disclosed: At present, some provinces/national procurement agencies have released relevant "distrustworthy information".
However, this untrustworthy information requires companies to find their own companies or competing companies based on their ratings
.
Once the platform can be queried publicly, that is to say, as long as the information in it meets the relevant ratings, it can be "used" when recruiting.
This is a point that companies should focus on
.
This information access personnel and sales personnel need to pay attention to it, and the price is very important for a product
.
